People have been found to lose large amounts of weight on the drug in trials, but it is not approved by the FDA for this purpose
RGCs are vulnerable to oxidative and inflammatory stressors and have been shown to be thinned in hyperglycemic conditions [8688]
This approach supports lasting health improvements beyond the period of medication use
The Compounded Semaglutide Trap Were Watching Happen Here is a pattern playing out for a lot of patients now: someone finds compounded semaglutide online for $200 per month they lose 25 pounds over eight months spending $1,600 then their telehealth provider loses legal access to compounded semaglutide as the shortage resolution takes effect the supply vanishes they cannot afford the $1,200 per month brand-name version they stop and within a year the weight returns
These patients receive a signal which tells them not only to eat more, but also to store more of what they eat. When semaglutide binds to the brains GLP-1 receptors, it blocks the AGRP pathway and stimulates the POMC pathway
It is manufactured by Novo Nordisk, the same company behind Ozempic and Victoza